Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck, Avillion ink development deal for nanobody psoriasis treatment
Merck, Avillion ink development deal for nanobody psoriasis treatment
Merck, Avillion ink development deal for nanobody psoriasis treatment
Submitted by
admin
on March 31, 2017 - 9:49am
Source:
Mass Device
News Tags:
Merck
Avillion
psoriasis
nanobodies
anti IL-17 A/F
Headline:
Merck, Avillion ink development deal for nanobody psoriasis treatment
Do Not Allow Advertisers to Use My Personal information
